» Articles » PMID: 24606905

Hypoglycemia-activated GLUT2 Neurons of the Nucleus Tractus Solitarius Stimulate Vagal Activity and Glucagon Secretion

Overview
Journal Cell Metab
Publisher Cell Press
Date 2014 Mar 11
PMID 24606905
Citations 71
Authors
Affiliations
Soon will be listed here.
Abstract

Glucose-sensing neurons in the brainstem participate in the regulation of energy homeostasis but have been poorly characterized because of the lack of specific markers to identify them. Here we show that GLUT2-expressing neurons of the nucleus of the tractus solitarius form a distinct population of hypoglycemia-activated neurons. Their response to low glucose is mediated by reduced intracellular glucose metabolism, increased AMP-activated protein kinase activity, and closure of leak K(+) channels. These are GABAergic neurons that send projections to the vagal motor nucleus. Light-induced stimulation of channelrhodospin-expressing GLUT2 neurons in vivo led to increased parasympathetic nerve firing and glucagon secretion. Thus GLUT2 neurons of the nucleus tractus solitarius link hypoglycemia detection to counterregulatory response. These results may help identify the cause of hypoglycemia-associated autonomic failure, a major threat in the insulin treatment of diabetes.

Citing Articles

Understanding glucose metabolism and insulin action at the blood-brain barrier: Implications for brain health and neurodegenerative diseases.

Zhu Y, Verkhratsky A, Chen H, Yi C Acta Physiol (Oxf). 2025; 241(2):e14283.

PMID: 39822067 PMC: 11737474. DOI: 10.1111/apha.14283.


Autophagy regulator ATG5 preserves cerebellar function by safeguarding its glycolytic activity.

Tutas J, Tolve M, Ozer-Yildiz E, Ickert L, Klein I, Silverman Q Nat Metab. 2025; 7(2):297-320.

PMID: 39815080 PMC: 11860254. DOI: 10.1038/s42255-024-01196-4.


Dorzagliatin: A Breakthrough Glucokinase Activator Coming on Board to Treat Diabetes Mellitus.

Raju R, Prabath I, Chandrasekaran I, Varadarajan S Cureus. 2024; 16(7):e65708.

PMID: 39211666 PMC: 11361462. DOI: 10.7759/cureus.65708.


Recent advances in understanding hypothalamic control of defensive responses to hypoglycaemia.

Staricoff E, Evans M Curr Opin Endocr Metab Res. 2024; 24:100353.

PMID: 39183767 PMC: 11339540. DOI: 10.1016/j.coemr.2022.100353.


Risks and Benefits of SGLT-2 Inhibitors for Type 1 Diabetes Patients Using Automated Insulin Delivery Systems-A Literature Review.

Elian V, Popovici V, Karampelas O, Gradisteanu Pircalabioru G, Radulian G, Musat M Int J Mol Sci. 2024; 25(4).

PMID: 38396657 PMC: 10888162. DOI: 10.3390/ijms25041972.